Saiyog Pharma Surgical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 6.13%
- Profit Growth 28.60%
- Ebitda 1400.45%
- Net Worth 26.07%
- Total Assets -7.99%
About Saiyog Pharma Surgical
Saiyog Pharma Surgical Private Limited (SPSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 May 2008 and has a history of 16 years and eight months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vijay Mulchandani, Pushpa Dayaldas, Kirti Sanjaykumar, and One other member serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33110MH2008PTC182840
-
Company No.
182840
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Saiyog Pharma Surgical Private Limited offer?
Saiyog Pharma Surgical Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Fracture Aid, Orthopedic Equipment & Supplies, Lower Body Orthotic Device, Rehabilitation Equipment, Upper Body Orthotic Devices, Rehabilitation Belts, Heat Therapy Equipments, Crepe Bandage, Medical Pillow.
Who are the key members and board of directors at Saiyog Pharma Surgical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Mulchandani
|
Director | 30-May-2008 | Current |
|
Pushpa Dayaldas
|
Director | 30-May-2008 | Current |
|
Kirti Sanjaykumar
|
Director | 30-May-2008 | Current |
|
Paresh Mulchandani
|
Director | 31-Mar-2011 | Current |
Financial Performance of Saiyog Pharma Surgical.
Saiyog Pharma Surgical Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.13% increase. The company also saw a substantial improvement in profitability, with a 28.6% increase in profit. The company's net worth Soared by an impressive increase of 26.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saiyog Pharma Surgical?
In 2021, Saiyog Pharma Surgical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Oxichem Exim LlpVijay Mulchandani and Paresh Mulchandani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saiyog Pharma Surgical?
Unlock and access historical data on people associated with Saiyog Pharma Surgical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saiyog Pharma Surgical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saiyog Pharma Surgical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
